Disparities in Fibroid Incidence, Prognosis, and Management.
Health disparities in fibroid prevalence, prognosis, and treatment exist for underserved women. Access to fibroid treatment alternatives can have significant effect on choices and outcomes of fibroid disease.
Department of Obstetrics & Gynecology and Surgery, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA; Department of Surgery, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address: Laughlintommaso.shannon@mayo.edu.
Shannon K
SK
Laughlin-Tommaso
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 2356 Sutter Street, San Francisco, CA 94115, USA.
Vanessa L
VL
Jacoby
Department of Obstetrics & Gynecology, Duke Clinical Research Institute, Duke University, 2400 Pratt Street, Durham, NC 27705, USA.
Evan R
ER
Myers
D001741:Black or African American; D005260:Female; D006297:Health Services Accessibility / Q000458:organization & administration / Q000706:statistics & numerical data*; D054625:Healthcare Disparities / Q000706:statistics & numerical data*; D006801:Humans; D007044:Hysterectomy / Q000706:statistics & numerical data*; D015994:Incidence; D007889:Leiomyoma / Q000453:epidemiology* / Q000208:ethnology / Q000628:therapy; D011379:Prognosis; D012424:Rural Population; D012720:Severity of Illness Index; D014481:United States / Q000453:epidemiology; D014594:Uterine Neoplasms / Q000453:epidemiology* / Q000208:ethnology / Q000628:therapy; D044465:White People
Disparity; Fibroid; Leiomyoma; Race; Rural; Socioeconomic status